Authors' Reply
- PMID: 36734843
- PMCID: PMC8054901
- DOI: 10.1681/ASN.2020121692
Authors' Reply
References
-
- Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, et al. .; WHO Solidarity Trial Consortium: Repurposed antiviral drugs for covid-19 - interim WHO solidarity trial results [published online ahead of print December 2, 2020]. N Engl J Med 10.1056/NEJMoa2023184 - PMC - PubMed
-
- Thakare S, Gandhi C, Modi T, Bose S, Deb S, Saxena N, et al. .: Safety of remdesivir in patients with acute or chronic kidney disease [published online ahead of print October 10, 2020]. Kidney Int Rep 10.1016/j.ekir.2020.10.005 - PubMed
-
- Estiverne C, Strohbehn IA, Mithani Z, Hirsch JS, Wanchoo R, Goyal PG, et al. .: Remdesivir in patients with estimated glomerular filtration rate < 30mL/min/1.73m2 or on renal replacement therapy [published online ahead of print November 27, 2020]. Kidney Int Rep 10.1016/j.ekir.2020.11.025 - PMC - PubMed
-
- Ackley TW, Mcmanus D, Topal JE, Cicali B, Shah S: A valid warning or clinical lore: An evaluation of safety outcomes of remdesivir in patients with impaired renal function from a multicenter matched cohort [published online ahead of print November 23, 2020]. Antimicrob Agents Chemother 10.1128/AAC.02290-20 - PMC - PubMed
LinkOut - more resources
Full Text Sources